Alexander Wolters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexander Wolters has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Reiner Benecke
Department of Neurology, University of Rostock, Rostock, Germany
3 shared publications - Ana Westenberger
Institute of Neurogenetics, University of Lübeck, Lübeck, Germany
1 shared publication - Christoph Kamm
Department of Neurology, University of Rostock, Rostock, Germany
1 shared publication Julia Ziegan
Department of Neurology, University of Rostock, Germany; Institute of Neurogenetics, University of Lübeck, Germany
1 shared publicationMatthias Wittstock
Department of Neurology, University of Rostock, Rostock, Germany
1 shared publication- Matthias Wittstock
Department of Neurology, University Medicine Rostock, 18057 Rostock, Germany
1 shared publication
Latest Publications
- 7 November 2014
- Published by Wiley in Movement Disorders
- Vol. 29 (14) , 1833-1834
NovelGNALmutations in two German patients with sporadic dystonia
- 7 November 2014
- Published by Wiley in Movement Disorders
- Vol. 29 (14) , 1833-1834
NovelGNALmutations in two German patients with sporadic dystonia
- 1 January 2014
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 4 (1) , 45-55
Asymmetric Postural Tremor Preceding DOPA-Responsive Parkinsonism – the Transition Disease
Background: Tremulous Parkinson's disease (PD) and essential tremor are well known to be associated, but characteristics of progression of pure tremor state to PD remain unclear. Objective: In this prospective study a cohort of 16 patients suffering from a suggested new disease entity was clinically, pharmacologically, and sonographically analyzed to evaluate whether characteristics giving rise to a new entity in this field can be detected. Methods: All patients had a history of asymmetric postural tremor (aPT) who either already had developed surplus Parkinsonism (PARK group), or were still in the state of a pure asymmetric postural tremor syndrome (APT group). Asymmetry of aPT was assessed by tremor scores including an asymmetry index. DOPA-responsivity was analyzed by tremor scores and the score of the motor part of the Unified Parkinson's disease rating scale. Transcranial brain sonography was performed to evaluate echogenicity of the substantia nigra. Results: Mean age at onset of asymmetric postural tremor was 57 ± 8.5 years without significant differences between both groups. Family history was compatible with an autosomal-dominant inheritance pattern in the majority of patients of both the APT and PARK group. All patients in the PARK group and 3 out of 8 patients in the APT group (38%) with respect to their asymmetric postural tremor were DOPA-responsive. All patients of both groups eligible to transcranial brain sonography showed hyperechogenicity of substantia nigra. In both groups, there was no correlation between tremor severity and duration of asymmetric postural tremor. Conclusions: Our data indicate that patients with an initial asymmetric and sometimes DOPA-responsive postural tremor syndrome and PARK patients are at various stages within the transition from aPT to a later developed DOPA-responsive Parkinsonian syndrome. It is postulated that the described group of patients may represent a separate disease entity with a hereditary background.
- 1 January 2014
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 4 (1) , 45-55
Asymmetric Postural Tremor Preceding DOPA-Responsive Parkinsonism – the Transition Disease
Background: Tremulous Parkinson's disease (PD) and essential tremor are well known to be associated, but characteristics of progression of pure tremor state to PD remain unclear. Objective: In this prospective study a cohort of 16 patients suffering from a suggested new disease entity was clinically, pharmacologically, and sonographically analyzed to evaluate whether characteristics giving rise to a new entity in this field can be detected. Methods: All patients had a history of asymmetric postural tremor (aPT) who either already had developed surplus Parkinsonism (PARK group), or were still in the state of a pure asymmetric postural tremor syndrome (APT group). Asymmetry of aPT was assessed by tremor scores including an asymmetry index. DOPA-responsivity was analyzed by tremor scores and the score of the motor part of the Unified Parkinson's disease rating scale. Transcranial brain sonography was performed to evaluate echogenicity of the substantia nigra. Results: Mean age at onset of asymmetric postural tremor was 57 ± 8.5 years without significant differences between both groups. Family history was compatible with an autosomal-dominant inheritance pattern in the majority of patients of both the APT and PARK group. All patients in the PARK group and 3 out of 8 patients in the APT group (38%) with respect to their asymmetric postural tremor were DOPA-responsive. All patients of both groups eligible to transcranial brain sonography showed hyperechogenicity of substantia nigra. In both groups, there was no correlation between tremor severity and duration of asymmetric postural tremor. Conclusions: Our data indicate that patients with an initial asymmetric and sometimes DOPA-responsive postural tremor syndrome and PARK patients are at various stages within the transition from aPT to a later developed DOPA-responsive Parkinsonian syndrome. It is postulated that the described group of patients may represent a separate disease entity with a hereditary background.
- 21 November 2012
- Published by Oxford University Press (OUP)
The cortical silent period
The cortical silent period (cSP) refers to an interruption of voluntary muscle contraction by transcranial stimulation of the contralateral motor cortex. This article summarizes the physiology of cSP and gives guidelines as to how the cSP should be recorded and analysed, and refers to useful clinical applications. It describes the mechanisms at the spinal and supraspinal level can account for the cSP. It is currently thought that the cSP is mediated by gamma-aminobutyric acid receptors. cSP measurements are easy to obtain but require a standardized protocol to allow useful interpretation. Conditioning electrical stimulation of cutaneous nerves shortens the cSP. A conditioning transcranial magnetic stimulation pulse also affects cSP duration. The cSP duration is influenced by pathological conditions. cSP is an attractive probe to assess motor cortical inhibition in health and disease.
- 21 November 2012
- Published by Oxford University Press (OUP)
The cortical silent period
The cortical silent period (cSP) refers to an interruption of voluntary muscle contraction by transcranial stimulation of the contralateral motor cortex. This article summarizes the physiology of cSP and gives guidelines as to how the cSP should be recorded and analysed, and refers to useful clinical applications. It describes the mechanisms at the spinal and supraspinal level can account for the cSP. It is currently thought that the cSP is mediated by gamma-aminobutyric acid receptors. cSP measurements are easy to obtain but require a standardized protocol to allow useful interpretation. Conditioning electrical stimulation of cutaneous nerves shortens the cSP. A conditioning transcranial magnetic stimulation pulse also affects cSP duration. The cSP duration is influenced by pathological conditions. cSP is an attractive probe to assess motor cortical inhibition in health and disease.
- 19 April 2012
- Vol. 154 (7) , 59-62
[Current strategies for the treatment of Parkinson's disease].
- 21 May 2007
- p. 94-6
[Diagnosis and treatment of tremor in Parkinson's disease and essential tremor].
For patients presenting predominantly or purely with tremor, the correct diagnosis of tremor-dominant Parkinson's disease (PD) versus essential tremor (ET) is very important for prognosis and effective therapy. ET tremor is usually characterized by symmetric bilateral postural and kinetic tremor, which may respond to low alcohol consumption. Many patients have a family history of ET tremors. Medical treatment with primidone or beta-blockers effectively controls ET tremor, but in many cases no treatment is needed at all. The typical tremor form of PD is an asymmetric rest tremor, which is treated with dopaminergic agents such as levodopa. Differential diagnosis of ET and PD may be difficult in a subset of PD patients who present with additional postural and kinetic tremor and in a minority of ET patients who show a clear asymmetry of their postural and kinetic tremor. In some patients with ET, the tremor can later become severe and even require treatment with deep brain stimulation.
- 21 May 2007
- p. 94-6
[Diagnosis and treatment of tremor in Parkinson's disease and essential tremor].
For patients presenting predominantly or purely with tremor, the correct diagnosis of tremor-dominant Parkinson's disease (PD) versus essential tremor (ET) is very important for prognosis and effective therapy. ET tremor is usually characterized by symmetric bilateral postural and kinetic tremor, which may respond to low alcohol consumption. Many patients have a family history of ET tremors. Medical treatment with primidone or beta-blockers effectively controls ET tremor, but in many cases no treatment is needed at all. The typical tremor form of PD is an asymmetric rest tremor, which is treated with dopaminergic agents such as levodopa. Differential diagnosis of ET and PD may be difficult in a subset of PD patients who present with additional postural and kinetic tremor and in a minority of ET patients who show a clear asymmetry of their postural and kinetic tremor. In some patients with ET, the tremor can later become severe and even require treatment with deep brain stimulation.